Rifampicin, RIF Or RMP Or R, AREA[OverallStatus], Open or Pending: 1 Clinical Trial

Novel Triple-dose Tuberculosis Retreatment Regimen

Condition(s):Multidrug-resistant Tuberculosis; Pulmonary Tuberculosis; Tuberculosis; Resistance to Tuberculostatic DrugsLast Updated:November 1, 2021Recruiting

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.